Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

24th-Mar-2011 10:47Source: BSE

Dr Reddys Labs - Allotment of Bonus Debentures

Dr Reddys Laboratories Ltd has informed BSE that the Management Committee of the Board of Directors of the Company at its meeting held on March 24, 2011, has approved the allotment of 1,015,516,392 Unsecured Redeemable Non-Convertible Debentures of Rs. 5/- each carrying a coupon of 9.25% per annum, ("Bonus Debentures") amounting to an aggregate value of Rs. 5,077,581,960/- from the General Reserve by way of distribution as bonus, to the Members, based on their equity holding on the Record Date i.e. March 18, 2011, in the ratio of 6 (six) Bonus Debentures of Rs. 5/- each for every equity share of Rs. 5/- each held.

This allotment has been made pursuant to the Scheme of Arrangement sanctioned by the Hon''ble High Court of Judicature, Andhra Pradesh at Hyderabad by its Order passed on July 19, 2010, approval of the Reserve Bank of India vide its letter dated January 14, 2011 (for the issue of Bonus Debentures to foreign shareholders) and subsequent No-objection from Income-tax department dated February 01, 2011. The Scheme came into effect on February 01, 2011.

The Bonus Debentures carry an interest at 9.25% per annum payable annually in arrears i.e. 1st year interest on March 24, 2012, 2nd year interest on March 24, 2013 and 3rd year and final interest together with the redemption proceeds on March 24, 2014. The Bonus Debentures have tenure of three years from the date of allotment and will be redeemed on March 24, 2014. Further, these debentures have been assigned a rating of LAA+ by ICRA.

Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2017-07-27

Quarterly Results

Sections
Follow us on
Available On